Literature DB >> 14552833

Differential signaling by CpG DNA in DCs and B cells: not just TLR9.

Daniela Verthelyi1, Rainald A Zeuner.   

Abstract

CpG-containing oligodeoxynucleotides (CpG ODNs) act on Toll-like receptor 9 (TLR9) that is expressed on B cells and plasmacytoid dendritic cells (pDCs) to stimulate the innate immune system, however, different types of CpG ODNs induce distinct responses. Recent papers suggest some CpG ODNs could require a second receptor or cofactor to signal. The different signaling complexes assembled might impact on the affinity with which CpG ODNs signal to TLR9 or activate additional pathways that lead to distinct immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552833     DOI: 10.1016/s1471-4906(03)00243-6

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  24 in total

1.  3'poly-G-tailed ODNs inhibit F-spondin to induce cell death and neurite retraction in rat embryonic neurons.

Authors:  Yung-Chih Cheng; Tai-An Chen; Chih-Yuan Chen; Chi-Ming Liang; Shu-Mei Liang
Journal:  Mol Neurobiol       Date:  2012-05-17       Impact factor: 5.590

2.  Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.

Authors:  Kenya Honda; Hideyuki Yanai; Tatsuaki Mizutani; Hideo Negishi; Naoya Shimada; Nobutaka Suzuki; Yusuke Ohba; Akinori Takaoka; Wen-Chen Yeh; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

3.  Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC.

Authors:  Kendra N Taylor; Monika Laszkowska; Evan Cohick; Yolonda L Colson
Journal:  Cell Immunol       Date:  2008-05-23       Impact factor: 4.868

4.  TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.

Authors:  Jessica E Thaxton; Roberto Romero; Surendra Sharma
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C.

Authors:  Björn Ingelsson; Daniel Söderberg; Tobias Strid; Anita Söderberg; Ann-Charlotte Bergh; Vesa Loitto; Kourosh Lotfi; Mårten Segelmark; Giannis Spyrou; Anders Rosén
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

Review 6.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

7.  Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls.

Authors:  Yun Sun; Xiaoli Qin; Bin Shan; Wenjing Wang; Qinling Zhu; Surendra Sharma; Ji Wu; Yi Lin
Journal:  Fertil Steril       Date:  2013-02-13       Impact factor: 7.329

8.  Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.

Authors:  Maurizio Chiriva-Internati; Yuefei Yu; Leonardo Mirandola; Marjorie R Jenkins; Caroline Chapman; Martin Cannon; Everardo Cobos; W Martin Kast
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

9.  High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

Authors:  Claudia Volpi; Francesca Fallarino; Maria T Pallotta; Roberta Bianchi; Carmine Vacca; Maria L Belladonna; Ciriana Orabona; Antonella De Luca; Louis Boon; Luigina Romani; Ursula Grohmann; Paolo Puccetti
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.